Landscapes / Companies
Compass Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials
Trials
4 active
6 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | 31 Aug 2027Phase 2/3 trial completes | |||
| Next date | 31 Aug 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Biliary Tract Cancer, Cholangiocarcinoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | Sep 2028Phase 2 trial completes | |||
| Next date | Sep 2028 · Phase 2 trial completes | ||||
| Also tested for | Neuroendocrine Neoplasm, Neuroendocrine Carcinomas and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer, Triple Negative Breast Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Apr 2028Phase 1 trial completes | |||
| Next date | 1 Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC) and 2 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021